Company: RPID
Filing Date: 2025-08-12
Form Type: 10-Q
Source: 0001380106-25-000174
Chunk: 339

Company: RAPID MICRO BIOSYSTEMS, INC.
Filing Date: 2025-08-12
Form: 10-Q
Item: Part I, Item 8
Chunk 339
---
 amended the Inducement Plan to reserve an additional 476,000 shares of its Class A common stock. The amendment was adopted by the Company's board of directors, without stockholder approval pursuant to Rule 5635(c)(4) of the Nasdaq Listing Rules.  In May 2025, the Company amended the Inducement Plan to reserve an additional 442,987 shares of its Class A common stock. The amendment was adopted by the Company's board of directors, without stockholder approval pursuant to Rule 5635(c)(4) of the Nasdaq Listing Rules.As of June 30, 2025, 250,000 shares were available for future issuance under the Inducement Plan. Stock optionsThe following table presents, on a weighted average basis, the assumptions used in the Black-Scholes option-pricing model to determine the grant-date fair value of stock options granted to employees and directors:Three Months Ended June 30,Six Months Ended June 30,2025202420252024Risk-free interest rate 4.2 %5.2 %4.3 %4.3 %Expected term (in years)5.95.56.05.9Expected volatility53.2 %50.9 %51.7 %49.8 %Expected dividend yield0 %0 %0 %0 %Stock optionsThe following table summarizes the Company’s stock option activity since December 31, 2024:Number of sharesWeighted average exercise priceWeighted average remaining contractual termAggregate intrinsic value(in years)(in thousands)Outstanding as of December 31, 20246,296,505$2.39 6.18$135 Granted 1,454,2503.43 Exercised(385,682)1.09 $589 Expired(74,833)8.22 Forfeited(189,414)2.47 Outstanding as of June 30, 20257,100,826$2.61 6.56$11,871 Options vested and expected to vest as of June 30, 20257,100,826$2.61 6.56$11,871 Options exercisable as of June 30, 20254,766,902$2.61 5.39$9,318 The aggregate intrinsic value of options is calculated as the difference between the exercise price of the stock options and the fair